Financials
- Market Capitalization 1.84 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-16.21
市销率
396.94
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2045 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.78 USD | +3.38% | +3.85% | +6.24% | +27.72% | 1.86 B USD | ||
| 2050 | INBX Inhibrx Biosciences, Inc. - Common Stock | 124.97 USD | +0.25% | +0.56% | +47.30% | +55.09% | 1.84 B USD | ||
| 2060 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.50% | -3.70% | +4.00% | -26.52% | 1.81 B USD | ||
| 2071 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.76 USD | +0.55% | -3.77% | +17.28% | -7.00% | 1.79 B USD |